adMare Bioinnovations and Medicine by Design partner to support translation priorities in the Toronto life sciences ecosystem
Partnership to accelerate health innovation commercialization in the Toronto life sciences ecosystem and in Canada
Partnership to accelerate health innovation commercialization in the Toronto life sciences ecosystem and in Canada
Polymer and tissue regeneration expert discussed her multi-pronged approach to seeking treatments for eye diseases
Medicine by Design’s Scientific Director, Michael Sefton, publishes an op-ed in the Hill Times.
"I hope that my work will one day be used across a wide range of applications. With all the complexities and unknowns of degenerative diseases, it’s important for us to explore new ideas."
Fund advances research discoveries to real benefit for human health
Convergent Working Groups aim to bring wide-ranging expertise and perspectives together
Community collaboration drove the new commitments in bold five-year plan
Matthew Buechler recently joined the Department of Immunology as an assistant professor.
"This is a very exciting time for regenerative medicine. We can make all sorts of cell types from stem cells and potentially use these cells for cell replacement therapy or use them to understand diseases or find new therapies."
Two new advisors with decades of industry experience join the program as advisors.
The Leap into the Future series looks at emerging areas or aspects of regenerative medicine.
Strategic partnership focuses on training the next generation of leaders, scientists and entrepreneurs.
The conference brought together entrepreneurs, academics, investors and policymakers.
Research grants awarded to products that could impact cancer and rare genetic diseases.
Research reveals a potential way to tailor acute myeloid leukemia (AML) therapies to individual patients.